Speaker illustration

Doctor Vincent Johan Nijenhuis

St Antonius Hospital, Nieuwegein (Netherlands (The))

Member of:

European Society of Cardiology

Role of clopidogrel loading dose in patients undergoing transcatheter aortic valve implantation: results from the BRAVO-3 randomized trial

Event: ESC Congress 2016

Topic: Non coronary cardiac interventions

Session: Current data on TAVI outcomes

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb